about
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, ...
Read More
20.72
-0.61
(-2.86%)
178.4K
XNAS Volume
XNAS 08 Aug, 2025 5:30 PM (EDT)
Board Meeting
The latest board meeting for Tourmaline Bio Inc took place on 08 Aug 2025, for the purpose of Tourmaline Bio Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Tourmaline Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..